newsfilter
← Latest News
Business Wire·

Catalent Appoints David McErlane as Biologics Segment Leader

Catalent, Inc. (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that David McErlane has been named Group President of Catalent's Biologics